Proteros Inks Deal to Provide Access to UC DCC's Screening Platform

In the deal with the University of Cincinnati, Drug Discovery Center, Proteros will provide biotechnology and drug firms access to UC DCC's ultra-high throughput and high-content screening platform along with a library of more than 340,000 drug-like compounds.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.